Reduced Intensity Conditioning | List of Frontiers open access articles

Original Research

Published on 04 Oct 2024

A comparison of haploidentical versus HLA-identical sibling outpatient hematopoietic cell transplantation using reduced intensity conditioning in patients with acute leukemia

in Alloimmunity and Transplantation

José Carlos Jaime-Pérez
Jorge Valdespino-Valdes
Andrés Gómez-De León
Renata Valeria Barragán-Longoria
Adriana Dominguez-Villanueva
Olga Graciela Cantú-Rodríguez
César Homero Gutiérrez-Aguirre
David Gómez-Almaguer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400610

3,913 views
2 citations

Case Report

Published on 29 Jan 2024

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature

in Hematologic Malignancies

Can Chen
Fan Yang
Peiwen Miu
Pengfei Shi
Shenxian Qian

Frontiers in Oncology

doi 10.3389/fonc.2024.1345464

3,786 views
4 citations

Review

Published on 15 Apr 2021

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia

in Hematologic Malignancies

Justin Loke
Hrushikesh Vyas
Charles Craddock

Frontiers in Oncology

doi 10.3389/fonc.2021.666091

6,862 views
18 citations

Mini Review

Published on 11 Jan 2016

Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?

in Hematology

Meral Beksac

Frontiers in Medicine

doi 10.3389/fmed.2015.00095

10,487 views
7 citations

Systematic Review

Published on 07 Oct 2021

Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation Is a Good Choice for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis of Randomized Controlled Trials

in Hematologic Malignancies

Yanzhi Song
Zhichao Yin
Jie Ding
Tong Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.708727

6,737 views
9 citations

Original Research

Published on 03 May 2023

Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens

in Hematologic Malignancies

Jiasheng Wang
Farhad Sanati
Amin Firoozmand
Pingfu Fu
Merle Kolk
Jane Reese-Koc
Marcos de Lima
Kirsten Boughan
Brenda Cooper
Paolo Caimi

Frontiers in Oncology

doi 10.3389/fonc.2023.1186532

2,039 views
3 citations

Original Research

Published on 02 Feb 2021

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

in Alloimmunity and Transplantation

Agnieszka Tomaszewska
Madan Jagasia
Eric Beohou
Steffie van der Werf
Didier Blaise
Edward Kanfer
Noel Milpied
Péter Reményi
Fabio Ciceri
Jean H. Bourhis

Frontiers in Immunology

doi 10.3389/fimmu.2020.613954

4,038 views
5 citations

Review

Published on 18 Jan 2023

The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review

in Hematologic Malignancies

Robert Puckrin
Mona Shafey
Jan Storek

Frontiers in Oncology

doi 10.3389/fonc.2022.1105779

6,431 views
8 citations

Review

Published on 23 Feb 2023

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review

in Hematology

Nishka Bhalla
Anjali Bhargav
Sandeep Kumar Yadav
Aloukick Kumar Singh

Frontiers in Medicine

doi 10.3389/fmed.2023.1036939

14,229 views
20 citations

Case Report

Published on 14 May 2019

Hematopoietic Stem Cell Transplant for the Treatment of X-MAID

in Pediatric Immunology

Sarah E. Henrickson
Isabelle Andre-Schmutz
Chantal Lagresle-Peyrou
Matthew A. Deardorff
Harumi Jyonouchi
Benedicte Neven
Nancy Bunin
Jennifer R. Heimall

Frontiers in Pediatrics

doi 10.3389/fped.2019.00170

5,500 views
17 citations

Review

Published on 02 May 2012

The use of donor-derived veto cells in hematopoietic stem cell transplantation

in Alloimmunity and Transplantation

Eran Ophir
Yair Reisner

Frontiers in Immunology

doi 10.3389/fimmu.2012.00093

7,645 views
10 citations

Case Report

Published on 29 Oct 2018

Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia

in Primary Immunodeficiencies

Shahrzad Bakhtiar
Sandra Woelke
Sabine Huenecke
Matthias Kieslich
Alexander Malcolm Taylor
Ralf Schubert
Stefan Zielen
Peter Bader

Frontiers in Immunology

doi 10.3389/fimmu.2018.02495

6,602 views
34 citations

Case Report

Published on 23 Aug 2022

Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient—a case report

in Primary Immunodeficiencies

Louise Helander
Chris McKinney
Kathleen Kelly
Samantha Mack
Mary Sanders
Janice Gurley
Larry J. Dumont
Kyle Annen

Frontiers in Immunology

doi 10.3389/fimmu.2022.994321

4,151 views
2 citations

Review

Published on 04 Jun 2024

Allogeneic stem cell transplantation in multiple myeloma: is there still a place?

in Hematologic Malignancies

Carmine Liberatore
Francesca Fioritoni
Mauro Di Ianni

Frontiers in Oncology

doi 10.3389/fonc.2024.1402106

5,407 views
5 citations

Brief Research Report

Published on 12 Jun 2023

Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon

in Cell and Stem Cell Transplantation

Jean El Cheikh
Ghassan Bidaoui
Layal Sharrouf
Ammar Zahreddine
Radwan Massoud
Rita Nehme
Nabila Kreidieh
Nour Moukalled
Iman Abou Dalle
Rami Mahfouz

Frontiers in Transplantation

doi 10.3389/frtra.2023.1149393

2,268 views
1 citation

Brief Research Report

Published on 08 Nov 2022

Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment

in Cell and Stem Cell Transplantation

Daniele Avenoso
Michelle Kenyon
Varun Mehra
Pramila Krishnamurthy
Austin Kulasekararaj
Shreyans Gandhi
Francesco Dazzi
Mili Naresh Shah
Henry Wood
Ye Ting Leung

Frontiers in Transplantation

doi 10.3389/frtra.2022.996003

3,537 views
3 citations

Articles

A comparison of haploidentical versus HLA-identical sibling outpatient hematopoietic cell transplantation using reduced intensity conditioning in patients with acute leukemia

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia

Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?

Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation Is a Good Choice for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis of Randomized Controlled Trials

Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review

Hematopoietic Stem Cell Transplant for the Treatment of X-MAID

The use of donor-derived veto cells in hematopoietic stem cell transplantation

Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia

Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient—a case report

Allogeneic stem cell transplantation in multiple myeloma: is there still a place?

Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon

Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment